» Articles » PMID: 36367687

Renal TLR-7/TNF-α Pathway As a Potential Female-specific Mechanism in the Pathogenesis of Autoimmune-induced Hypertension

Abstract

Hypertension is prevalent in patients with systemic lupus erythematosus (SLE). The goal of the current study is to track the pathogenesis of hypertension and renal injury in SLE, identify contributory mechanisms, and highlight differences in disease development among sexes. Mean arterial pressure was measured in conscious male and female SLE () and control () mice at 34-35 wk of age using indwelling arterial catheters. Measures of renal injury, renal inflammation, and renal hemodynamics were used to monitor the potential contributors to latent sex differences. Both male and female SLE mice were hypertensive at 35 wk of age, and the hypertension was linked to renal injury in females, but not in males. A known contributor of renal pathology in SLE, Toll-like receptor (TLR)-7, and its downstream effector, the proinflammatory cytokine tumor necrosis factor (TNF)-α, were lower in male SLE mice than in females. Male SLE mice also had higher glomerular filtration rate (GFR) and lower renal vascular resistance (RVR) than females. Our data suggest that although hypertension in female SLE mice is associated with renal mechanisms, hypertension in male SLE mice may develop independent of renal changes. Future studies will continue to dissect sex-specific factors that should be considered when treating patients with hypertension with underlying chronic inflammation and/or autoimmunity. There is a high prevalence of hypertension in male and female SLE; however, male SLE mice are hypertensive without renal involvement. The development of hypertension in female SLE mice is renocentric and strongly associated with injurious renal mechanisms like the TLR-7→TNF-α pathway. This clear difference in the pathogenesis among the sexes could have a significant impact on how we treat patients with hypertension with underlying chronic autoimmune/inflammatory diseases.

Citing Articles

Steering toward new horizons: a vision for the future of the .

Rahmouni K Am J Physiol Regul Integr Comp Physiol. 2024; 327(6):R525-R527.

PMID: 39400578 PMC: 11687851. DOI: 10.1152/ajpregu.00252.2024.


Reconstituted HDL ameliorated renal injury of diabetic kidney disease in mice.

Tao Y, Lacko A, Sabnis N, Das-Earl P, Ibrahim D, Crowe N Physiol Rep. 2024; 12(15):e16179.

PMID: 39107084 PMC: 11303015. DOI: 10.14814/phy2.16179.


Hemodynamic Renal Reserve Response in Conscious Normotensive and Hypertensive Mice.

Tran M, Liu C, Naeem M, Parris C, Wang L Kidney Blood Press Res. 2024; 49(1):173-183.

PMID: 38350434 PMC: 11042998. DOI: 10.1159/000537806.


Sex as a biological variable for cardiovascular physiology.

Lindsey M, Usselman C, Ripplinger C, Carter J, DeLeon-Pennell K Am J Physiol Heart Circ Physiol. 2023; 326(3):H459-H469.

PMID: 38099847 PMC: 11219053. DOI: 10.1152/ajpheart.00727.2023.


Sex and strain differences in renal hemodynamics in mice.

Tao Y, Young-Stubbs C, Yazdizadeh Shotorbani P, Su D, Mathis K, Ma R Physiol Rep. 2023; 11(6):e15644.

PMID: 36946063 PMC: 10031302. DOI: 10.14814/phy2.15644.


References
1.
Cervera R, Khamashta M, Font J, Sebastiani G, Gil A, Lavilla P . Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1993; 72(2):113-24. View

2.
Chi M, Ma K, Li Y, Quan M, Han Z, Ding Z . Immunological Involvement of MicroRNAs in the Key Events of Systemic Lupus Erythematosus. Front Immunol. 2021; 12:699684. PMC: 8365877. DOI: 10.3389/fimmu.2021.699684. View

3.
Doxsee C, Riter T, Reiter M, Gibson S, Vasilakos J, Kedl R . The immune response modifier and Toll-like receptor 7 agonist S-27609 selectively induces IL-12 and TNF-alpha production in CD11c+CD11b+CD8- dendritic cells. J Immunol. 2003; 171(3):1156-63. DOI: 10.4049/jimmunol.171.3.1156. View

4.
Tan T, Fang H, Magder L, Petri M . Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol. 2012; 39(4):759-69. PMC: 3605704. DOI: 10.3899/jrheum.111061. View

5.
Bomback A, Appel G . Updates on the treatment of lupus nephritis. J Am Soc Nephrol. 2010; 21(12):2028-35. DOI: 10.1681/ASN.2010050472. View